Levetiracetam and Myobloc drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Levetiracetam and Myobloc together.
The phase IV clinical study analyzes what interactions people who take Levetiracetam and Myobloc have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Levetiracetam and Myobloc together, and have interactions are studied.
What is Levetiracetam?
Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 60,637 Levetiracetam users for its effectiveness, alternative drugs and more.
What is Myobloc?
Myobloc has active ingredients of botulinum toxin type b. eHealthMe is studying from 500 Myobloc users for its effectiveness, alternative drugs and more.
Number of Levetiracetam and Myobloc reports submitted per year:
Common Levetiracetam and Myobloc drug interactions by gender *:
female:
n/a
male:
- Parkinson's disease
* Approximation only. Some reports may have incomplete information.
Do you take Levetiracetam and Myobloc?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Levetiracetam (60,637 reports)
- Myobloc (500 reports)
Browse all drug interactions of Levetiracetam and Myobloc:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Levetiracetam side effects:
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7,432 reports
- Drug ineffective: 6,092 reports
- Fatigue (feeling of tiredness): 2,576 reports
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2,063 reports
- Drowsiness: 1,815 reports
- Dizziness: 1,781 reports
Browse all side effects of Levetiracetam:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Myobloc side effects:
- Swallowing difficulty: 116 reports
Browse all side effects of Myobloc:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Levetiracetam interactions:
- Levetiracetam and Lamotrigine: 6,562 reports
- Levetiracetam and Valproic acid: 4,986 reports
- Levetiracetam and Lacosamide: 4,346 reports
- Levetiracetam and Carbamazepine: 4,127 reports
- Levetiracetam and Topiramate: 4,126 reports
- Levetiracetam and Clobazam: 3,769 reports
- Levetiracetam and Clonazepam: 3,614 reports
- Levetiracetam and Loraz: 3,300 reports
- Levetiracetam and Gabapentin: 2,885 reports
- Levetiracetam and Omeprazole: 2,676 reports
Browse all interactions between Levetiracetam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on levetiracetam and botulinum toxin type b (the active ingredients of Levetiracetam and Myobloc, respectively), and Levetiracetam and Myobloc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Levetiracetam and Myobloc.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cortef and Rickets - 2 seconds ago
- Viracept and Lump In The Abdomen - 3 seconds ago
- Vecuronium Bromide and Hepatitis Aggravated - 14 seconds ago
- Buprenorphine Hydrochloride and Hypokalemia - 22 seconds ago
- Effexor and Nabumetone drug interaction - 23 seconds ago
- Zide and Infantile Apnoeic Attack - 23 seconds ago
- Taltz and Diabetes - 28 seconds ago
- Nadolol and Emotional Distress - 45 seconds ago
- Seroquel Xr and Montelukast Sodium drug interaction - 51 seconds ago
- Abilify and Xenazine drug interaction - 56 seconds ago